Ensysce Biosciences (ENSC) announced continued subject enrollment and successful dosing augmenting the progress of its second clinical trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback